Home » Firm: Covaxin trial on until April, emergency use doable earlier | India News

Firm: Covaxin trial on until April, emergency use doable earlier | India News

by newsking24

HYDERABAD: Bharat Biotech, which is growing India’s first indigenous Covid-19 vaccine, Covaxin, expects the important Phase III trials to be accomplished after April 2021. Only after that may the corporate go for business licensing and WHO pre-qualification, a high official of the corporate mentioned.
However, Covaxin may very well be accessible for emergency use earlier if the federal government decides to not look ahead to the completion of Phase III research and invokes an emergency use authorisation (EUA), Sai Prasad, govt director, Bharat Biotech International Ltd, informed TOI.
“We expect Phase III studies to begin in November and the first set of efficacy readouts will be available only by April or May of 2021. We have been providing all information on all aspects of our projects to the government… there have been discussions within the government on when to potentially introduce the vaccine, so whether they (government) will wait for our Phase III data or introduce it before is their prerogative,” he defined.
Prasad mentioned they’ll churn out 150 million doses per yr from their present services.

Source hyperlink

Related Articles

Leave a Reply

Select Language »
%d bloggers like this: